• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR 11.9% 48.0¢

PARADIGM BIOPHARMACEUTICALS LIMITED..

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAR
Chart
77 78 79
06/02/25 4.6K 4.0M
06/02/25 Last post  Wazz101 Comments Created with Sketch.  4.6K  Views Created with Sketch.  4.0M 
PAR 06/02/25 221 54K
06/02/25 Last post  bobsee Comments Created with Sketch.  221  Views Created with Sketch.  54K 
PAR
2025 partnership
2 3
06/02/25 158 51K
06/02/25 Last post  TheAnalyst007 Comments Created with Sketch.  158  Views Created with Sketch.  51K 
PAR
Coppo report today - multiple pharma engaged....
04/02/25 25 8.1K
04/02/25 Last post  Mozzarc Comments Created with Sketch.  25  Views Created with Sketch.  8.1K 
PAR 03/02/25 18 6.2K
03/02/25 Last post  TheAnalyst007 Comments Created with Sketch.  18  Views Created with Sketch.  6.2K 
PAR 03/02/25 0 476
03/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  476 
PAR 03/02/25 0 456
03/02/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  456 
PAR
Expanding our horizons
02/02/25 19 9.6K
02/02/25 Last post  Friendsandco Comments Created with Sketch.  19  Views Created with Sketch.  9.6K 

See All Discussions arrow Created with Sketch.

Timeline

Proposed issue of securities - PAR
03 Feb 08:28
 
Cancel - Proposed issue of securities - PAR
03 Feb 08:28
 
Proposed issue of securities - PAR
31 Jan 16:29
 
Loyalty and Piggyback Options Program
31 Jan 15:39
 
PAR Selects Advanced Clinical as CRO for Phase 3
31 Jan 08:19
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 15:28
 
View More arrow Created with Sketch.
(20min delay)
Last
48.0¢
Change
-0.065(11.9%)
Mkt cap ! $186.9M
Open High Low Value Volume
54.5¢ 54.5¢ 47.5¢ $1.598M 3.203M

Buyers (Bids)

No. Vol. Price($)
1 2988 48.0¢
 

Sellers (Offers)

Price($) Vol. No.
48.5¢ 98526 1
View Market Depth
Last trade - 16.10pm 06/02/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.